Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of silymarin in patients with multiple sclerosis
IRCT20150628022956N7Phase 2Completed
- Sponsor
- Research Council of Hamedan University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of silymarin in multiple sclerosis (MS) and hepatic disease, sponsored by Research Council of Hamedan University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
silymarin
03
Conditions
multiple sclerosis (MS)hepatic disease
Beyond the preview
Go deeper on IRCT20150628022956N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150628022956N7.